Cargando…
Matrix therapy is a cost-effective solution to reduce amputation risk and improve quality of life: pilot and case studies
Introduction: Chronic, non-healing ulcers remain one of the most challenging clinical situations for health care practitioners. Often, conventional treatments fail and lead to amputation, further decreasing the patient's quality of life and resulting in enormous medical expenditures for healthc...
Autores principales: | Desgranges, Pascal, Louissaint, Taina, Godeau, Bertrand, Barritault, Denis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
EDP Sciences
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6902838/ https://www.ncbi.nlm.nih.gov/pubmed/31821145 http://dx.doi.org/10.1051/rmr/190002 |
Ejemplares similares
-
ReGeneraTing Agents (RGTA
(®)) are a new option to improve amputation outcomes in the recovery of severe hand injuries
por: Ahmad, Roohi Sharifah, et al.
Publicado: (2018) -
A Rapid Response to Matrix Therapy With RGTA in Severe Epidermolysis Bullosa
por: Malaq, Ali Al, et al.
Publicado: (2012) -
Case Reports for Topical Treatment of Corneal Ulcers with a New Matrix Therapy Agent or RGTA(®) in Dogs
por: Martinez, Jessica A., et al.
Publicado: (2019) -
Evaluation of a new matrix regenerating agent in patients with Sjögren syndrome and superficial ulcerative keratitis resistant to conventional therapy: A report of 3 cases
por: Fajnkuchen, Franck, et al.
Publicado: (2018) -
Quality of Life and Life after Amputation among Amputees in Lagos, Nigeria
por: Enweluzo, George. O., et al.
Publicado: (2023)